You have access
The Use of Toll-like Receptor 4 Agonist to Reshape the Immune Signature in Ovarian Cancer
EVA VINDEVOGEL, THAÏS BAERT, ANAÏS VAN HOYLANDT, GODELIEVE VERBIST, GREETJE VANDE VELDE, ABHISHEK D. GARG, PATRICIA AGOSTINIS, IGNACE VERGOTE and AN COOSEMANS
Anticancer Research November 2016, 36 (11) 5781-5792;